all 1 comments

[–]Centaurea 2 insightful - 1 fun2 insightful - 0 fun3 insightful - 1 fun -  (0 children)

BioNTech starts human trial to test malaria vaccine.

BioNTech is Pfizer's German partner in its Covid-19 mRNA injections.

https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-initiates-clinical-trial-mrna-based-malaria-vaccine-candidate-2022-12-23/

After decades of work, the only approved malaria vaccine, Mosquirix, made by British drugmaker GSK (GSK.L), was this year endorsed by the World Health Organization (WHO), but a lack of funding and commercial potential has thwarted GSK's capacity to produce as many doses as needed.

Translation: it won't make enough $$$$$ to maximize corporate share value on Wall Street, so it won't be used to help people. Big Pharma has its Big Bucks in mRNA technology, and that's that.

BioNTech's malaria vaccine effort is based on its mRNA technology, which was employed during the pandemic to quickly develop COVID-19 vaccines, by prompting the human body to make a protein that is part of the pathogen, triggering an immune response.

Here we go again. As Bayer Pharmaceuticals president Stefan Oelrich said in his keynote address at the recent 2021 World Health Summit, mRNA Covid injections are "cellular gene therapy". In his statement, he celebrates the fact that the recent Covid-19 pandemic has caused the public to accept being given gene therapy.

https://youtu.be/2D5KeniMzjg

Here's the entire speech:

https://youtu.be/IKBmVwuv0Qc